Glycoprotein (gp) - Infectious Diseases

Relevant Publications

Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors.

Issue Release: 2024

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta-analysis.

Issue Release: 2024

Comparison of P-glycoprotein gene expression of two Haemonchus contortus isolates from Yucatan, Mexico, with resistant or susceptible phenotype to ivermectin in relation to a susceptible reference strain.

Issue Release: 2024

Research progress on pharmacological effects and bioavailability of berberine.

Issue Release: 2024

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.

Issue Release: 2024

Development of an evaluation system using intestinal organoids for drug efflux transport analysis by an imaging approach.

Issue Release: 2024

Ironing out the Links: Ferroptosis in epilepsy and SUDEP.

Issue Release: 2024

The ATP-Binding Cassette Transporter-Mediated Efflux Transport of Ganciclovir at the Blood-Brain Barrier.

Issue Release: 2024

High Levels of Triggering Receptor Expressed in Myeloid Cells-Like Transcript-1 Positive, but Not Glycoprotein 1b+, Microparticles Are Associated With Poor Outcomes in Acute Respiratory Distress Syndrome.

Issue Release: 2024

Role of P-glycoprotein in Regulating the Efficacy, Toxicity and Pharmacokinetics of Yunaconitine.

Issue Release: 2024

Effect of midostaurin on the pharmacokinetics of P-gp, BCRP, and CYP2D6 substrates: assessing potential drug-drug interactions in healthy participants : Brief title: Drug-drug interaction of midostaurin.

Issue Release: 2024

[P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier].

Issue Release: 2024

In Vitro Investigations into the Potential Drug Interactions of Pseudoginsenoside DQ Mediated by Cytochrome P450 and Human Drug Transporters.

Issue Release: 2024

Effect of carvedilol on pharmacokinetics of sofosbuvir and its metabolite GS-331007: role of P-glycoprotein.

Issue Release: 2024

Oral docetaxel plus encequidar - a phase 1 clinical trial.

Issue Release: 2024

The PACS-2 protein and trafficking motifs in CCHFV Gn and Gc cytoplasmic domains govern CCHFV assembly.

Issue Release: 2024

Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement.

Issue Release: 2024

Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins.

Issue Release: 2024

Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL Study.

Issue Release: 2024

Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.

Issue Release: 2024

What is an Apicoplast?

What is Genomics?

Are There Any Side Effects?

Why is Immune System Stimulation Important?

What is Hepatitis B?

What Are Some Examples of Inherited Immunity?

How is a Throat Swab Performed?

How Can Gonorrhea be Prevented?

What are the Criteria for Eradication?

How Does Lipid Metabolism Influence Pathogen Resistance?

Partnered Content Networks

Relevant Topics